ScholarIQanswers from OpenAlex & ORCID
M. Bagot
ResearcherPublications, citations & collaboration network
M. Bagot is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does M. Bagot have?
ScholarIQindexed works
M. Bagot has 909 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does M. Bagot have?
ScholarIQcitation count
M. Bagot has 19,653 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of M. Bagot?
ScholarIQh-index
M. Bagot has an h-index of 67 in OpenAlex.
What is the i10-index of M. Bagot?
ScholarIQi10-index
M. Bagot has an i10-index of 278 in OpenAlex.
What is the ORCID of M. Bagot?
ScholarIQorcid
The ORCID for M. Bagot is on the source record.
What is the OpenAlex record for M. Bagot?
ScholarIQopenalex
The OpenAlex for M. Bagot is on the source record.
What are the most-cited papers on M. Bagot?
ScholarIQmost cited works
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
Elise A. Olsen, Sean Whittaker, Youn H. Kim, Madeleine Duvic, H. Miles Prince, Stuart R. Lessin, Gary S. Wood, Rein Willemze, Marie‐France Demierre, Nicola Pimpinelli, Maria Grazia Bernengo, Pablo L. Ortiz‐Romero, M. Bagot, Teresa Estrach, Joan Guitart, Robert Knobler, José Antônio Sanches, Keiji Iwatsuki, Makoto Sugaya, Reinhard Dummer, Mark R. Pittelkow, Richard T. Hoppe, Sareeta Parker, Larisa J. Geskin, Lauren Pinter‐Brown, Michael Girardi, Günter Burg, Annamari Ranki, Maarten H. Vermeer, Sarah McCue Horwitz, Peter Heald, Steven T. Rosen, Lorenzo Cerroni, Brigette Dréno, Eric C. Vonderheid
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial
Youn H. Kim, M. Bagot, Lauren Pinter‐Brown, Alain H. Rook, Pierluigi Porcu, Sarah McCue Horwitz, Sean Whittaker, Y. Tokura, Maarten H. Vermeer, Pier Luigi Zinzani, Lubomir Sokol, Stephen Morris, Ellen J. Kim, Pablo L. Ortiz‐Romero, Herbert Eradat, Julia Scarisbrick, Athanasios Tsianakas, Craig A. Elmets, Stéphane Dalle, David C. Fisher, Ahmad Halwani, Brian Poligone, John P. Greer, Maria Teresa Fierro, Amit Khot, Alison J. Moskowitz, Amy Musiek, Andrei R. Shustov, Barbara Pro, Larisa J. Geskin, Karen M. Dwyer, Junji Moriya, Mollie Leoni, Jeffrey S. Humphrey, Stacie Hudgens, Dmitri O. Grebennik, Kensei Tobinai, Madeleine Duvic, Sunil Abhyankar, Oleg E. Akilov, Önder Alpdoğan, M. Beylot‐Barry, Erin Boh, Dolores Caballero, Richard Cowan, Brigitte Dréno, Reinhard Dummer, Timothy S. Fenske, Francine Foss, Noriko Fukuhara, Pratyush Giri, Koji Habe, Toshihisa Hamada, Kiyohiko Hatake, Shinsuke Iida, Osamu Ishikawa, Lars Iversen, Eiji Kiyohara, Hiroshi Koga, Neil J. Korman, Bryone J. Kuss, Zanetta S. Lamar, Frederick Lansigan, Mary Jo Lechowicz, Adam Lerner, Nina Magnolo, Lawrence A. Mark, Tomomitsu Miyagaki, Javier Muñoz, Jan P. Nicolay, Kaoru Nishiwaki, Hiroyuki Okamoto, Mikio Ohtsuka, Theresa Pacheco, Christiane Querfeld, Ronald Peter Rapini, Shigetoshi Sano, Maiko Tanaka, Michael D. Tharp, Jiro Uehara, Hidefumi Wada, Jillian Wells, Ryan A. Wilcox, Basem M. William, Kentaro Yonekura
European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome – Update 2017
Franz Trautinger, Johanna Eder, Chalid Assaf, M. Bagot, Antonio Cozzio, Reinhard Dummer, Robert Gniadecki, Claus‐Detlev Klemke, Pablo L. Ortiz‐Romero, Evangelia Papadavid, Nicola Pimpinelli, Pietro Quaglino, Annamari Ranki, Julia Scarisbrick, Rudolf Stadler, Liisa Väkevä, Maarten H. Vermeer, Sean Whittaker, Rein Willemze, Robert Knobler
Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model
Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer, Pietro Quaglino, Sarah McCue Horwitz, Pierluigi Porcu, Rudolf Stadler, Gary S. Wood, M. Beylot‐Barry, Anne Pham‐Ledard, Francine M. Foss, Michael Girardi, M. Bagot, Laurence Michel, Maxime Battistella, Joan Guitart, Timothy M. Kuzel, Maria Estela Martínez‐Escala, Teresa Estrach, Evangelia Papadavid, Christina Antoniou, Dimitis Rigopoulos, Vassilki Nikolaou, Makoto Sugaya, Tomomitsu Miyagaki, Robert Gniadecki, José Antônio Sanches, Jade Cury‐Martins, Denis Miyashiro, Octavio Servitje, Cristina Muniesa, Emilio Berti, Francesco Onida, Laura Corti, Emilia Hodak, Iris Amitay‐Laish, Pablo L. Ortiz‐Romero, José Luis Rodríguez‐Peralto, Robert Knobler, Stefanie Porkert, Wolfgang Bauer, Nicola Pimpinelli, Vieri Grandi, Richard Cowan, Alain H. Rook, Ellen Kim, Alessandro Pileri, Annalisa Patrizi, Ramón M. Pujol, Henry K. Wong, Kelly Tyler, René Stranzenbach, Christiane Querfeld, Paolo Fava, Milena Maule, Rein Willemze, Felicity Evison, Stephen Morris, Robert Twigger, Rakhshandra Talpur, Jinah Kim, G. Ognibene, Shufeng Li, Mahkam Tavallaee, Richard T. Hoppe, Madeleine Duvic, Sean Whittaker, Youn H. Kim
EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*
Werner Kempf, Katrin Pfaltz, Maarten H. Vermeer, Antonio Cozzio, Pablo L. Ortiz‐Romero, M. Bagot, Elise A. Olsen, Youn H. Kim, Reinhard Dummer, Nicola Pimpinelli, Sean Whittaker, Emmilia Hodak, Lorenzo Cerroni, Emilio Berti, Steve Horwitz, H. Miles Prince, Joan Guitart, Teresa Estrach, José Antônio Sanches, Madeleine Duvic, Annamari Ranki, Brigitte Dréno, Sonja Ostheeren-Michaelis, Robert Knobler, Gary S. Wood, Rein Willemze